Reconstruction of integrin activation

Blood

Volumn 119, Issue 1, 2012, Pages 26-33

  Ye, Feng ^a   Kim, Chungho ^a   Ginsberg, Mark H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; INTEGRIN; INTEGRIN RECEPTOR; LACTOSE PERMEASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

CELL ADHESION; CELL MEMBRANE; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE MUTATION; HEMATOPOIESIS; HEMOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84862924585     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-292128     Document Type: Review

References (120)

1. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673-687. (Pubitemid 35283958)
2. Coller BS, Shattil SJ. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood. 2008;112(8):3011-3025.
3. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. 1998;91(8): 2645-2657. (Pubitemid 28227512)
4. Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol. 2010;11(4):288-300.
5. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004;104(6):1606-1615. (Pubitemid 39202265)
6. Tronik-Le Roux D, Roullot V, Poujol C, Kortulewski T, Nurden P, Marguerie G. Thrombasthenic mice generated by replacement of the integrin alpha(IIb) gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment. Blood. 2000; 96(4):1399-1408. (Pubitemid 30658470)
7. Tomiyama Y. Glanzmann thrombasthenia: integrin alpha IIb beta 3 deficiency. Int J Hematol. 2000;72(4):448-454.
8. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. Beta3-integrin- deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999; 103(2):229-238. (Pubitemid 29053141)
9. Coller BS, Seligsohn U, Peretz H, Newman PJ. Glanzmann thrombasthenia: new insights from an historical perspective. Semin Hematol. 1994; 31(4):301-311. (Pubitemid 24325182)
10. .Wang R, Shattil SJ, Ambruso DR, Newman PJ. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex. J Clin Invest. 1997; 100(9):2393-2403. (Pubitemid 27500165)
11. Chen YP, Djaffar I, Pidard D, et al. Ser-752->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci U S A. 1992;89(21):10169-10173.
12. Hogg N, Bates PA. Genetic analysis of integrin function in man: LAD-1 and other syndromes. Matrix Biol. 2000;19(3):211-222. (Pubitemid 30601754)
13. Svensson L, Howarth K, McDowall A, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med. 2009;15(3):306-312.
14. Malinin NL, Zhang L, Choi J, et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med. 2009;15(3): 313-318.
15. Kuijpers TW, van de Vijver E, Weterman MA, et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood. 2009;113(19):4740- 4746.
16. Alon R, Etzioni A. LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24(10):561-566. (Pubitemid 37205208)
17. McDowall A, Svensson L, Stanley P, et al. Two mutations in the KINDLIN3 gene of a new leukocyte adhesion deficiency III patient reveal distinct effects on leukocyte function in vitro. Blood. 2010; 115(23):4834-4842.
18. Lai-Cheong JE, McGrath JA. Kindler syndrome. Dermatol Clin. 2010;28(1):119-124.
19. D'Souza MA, Kimble RM, McMillan JR. Kindler syndrome pathogenesis and fermitin family homologue 1 (kindlin-1) function. Dermatol Clin. 2010;28(1):115-118.
20. Quinn MJ, Byzova TV, Qin J, Topol EJ, Plow EF. Integrin alphaIIbbeta3 and its antagonism. Arterioscler Thromb Vasc Biol. 2003;23(6):945-952.
21. Millard M, Odde S, Neamati N. Integrin targeted therapeutics. Theranostics. 2011;1:154-188.
22. Stock D, Gibbons C, Arechaga I, Leslie AG, Walker JE. The rotary mechanism of ATP synthase. Curr Opin Struct Biol. 2000;10(6):672-679. (Pubitemid 32061482)
23. Yao X, Parnot C, Deupi X, et al. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol. 2006; 2(8):417-422. (Pubitemid 44114919)
24. Guan L, Kaback HR. Lessons from lactose permease. Annu Rev Biophys Biomol Struct. 2006; 35:67-91. (Pubitemid 43877370)
25. Morera FJ, Vargas G, Gonzalez C, Rosenmann E, Latorre R. Ion-channel reconstitution. Methods Mol Biol. 2007;400:571-585. (Pubitemid 350183715)
26. Sambongi Y, Iko Y, Tanabe M, et al. Mechanical rotation of the c subunit oligomer in ATP synthase (F0F1): direct observation. Science. 1999; 286(5445):1722-1724. (Pubitemid 129515876)
27. Yasuda R, Noji H, Kinosita K Jr, Yoshida M. F1-ATPase is a highly efficient molecular motor that rotates with discrete 120 degree steps. Cell. 1998;93(7):1117-1124. (Pubitemid 28307417)
28. Noji H, Yasuda R, Yoshida M, Kinosita K Jr. Direct observation of the rotation of F1-ATPase. Nature. 1997;386(6622):299-302.
29. Han J, Lim CJ, Watanabe N, et al. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol. 2006;16(18): 1796-1806. (Pubitemid 44354146)
30. Lee HS, Lim CJ, Puzon-McLaughlinW, Shattil SJ, Ginsberg MH. RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J Biol Chem. 2009;284(8):5119-5127.
31. .Watanabe N, Bodin L, Pandey M, et al. Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. J Cell Biol. 2008;181(7):1211-1222. (Pubitemid 351915493)
32. Xiao T, Takagi J, Coller BS,Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004;432(7013):59-67. (Pubitemid 39490825)
33. Xiong JP, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 2001;294(5541):339-345. (Pubitemid 32963395)
34. Xiong JP, Stehle T, Zhang R, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science. 2002;296(5565):151-155. (Pubitemid 34280076)
35. Zhu J, Luo BH, Xiao T, Zhang C, Nishida N, Springer TA. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell. 2008;32(6):849-861.
36. Anthis NJ, Wegener KL, Ye F, et al. The structure of an integrin/talin complex reveals the basis of inside-out signal transduction. EMBO J. 2009; 28(22):3623-3632.
37. Lau TL, Kim C, Ginsberg MH, Ulmer TS. The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J. 2009;28(9):1351-1361.
38. .Wegener KL, Partridge AW, Han J, et al. Structural basis of integrin activation by talin. Cell. 2007;128(1):171-182. (Pubitemid 46048890)
39. Adair BD, Xiong JP, Maddock C, Goodman SL, Arnaout MA, Yeager M. Three-dimensional EM structure of the ectodomain of integrin-alphaV-beta3 in a complex with fibronectin. J Cell Biol. 2005;168(7):1109-1118.
40. Chen X, Xie C, Nishida N, Li Z,Walz T, Springer TA. Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2. Proc Natl Acad Sci U S A. 2010;107(33):14727-14732.
41. Nishida N, Xie C, Shimaoka M, Cheng Y, Walz T, Springer TA. Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. Immunity. 2006;25(4):583-594. (Pubitemid 44529036)
42. Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extra-cellular domains in outside-in and inside-out signaling. Cell. 2002;110(5):599-611. (Pubitemid 35247840)
43. Ye F, Hu G, Taylor D, et al. Re-creation of the terminal events in physiological integrin activation. J Cell Biol. 2010;188(1):157-173.
44. O'Toole TE, Loftus JC, Du XP, et al. Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul. 1990;1(12):883-893.
45. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem. 1999;274(40):28071-28074.
46. Tadokoro S, Shattil SJ, Eto K, et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science. 2003;302(5642):103- 106. (Pubitemid 37210697)
47. Goksoy E, Ma YQ, Wang X, et al. Structural basis for the autoinhibition of talin in regulating integrin activation. Mol Cell. 2008;31(1):124-133. (Pubitemid 351905930)
48. Garcia-Alvarez B, de Pereda JM, Calderwood DA, et al. Structural determinants of integrin recognition by talin. Mol Cell. 2003;11(1):49-58. (Pubitemid 36131107)
49. Moser M, Bauer M, Schmid S, et al. Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med. 2009; 15(3):300-305.
50. Ussar S, Moser M, Widmaier M, et al. Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet. 2008;4(12):e1000289.
51. Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med. 2008; 14(3):325-330. (Pubitemid 351347914)
52. Montanez E, Ussar S, Schifferer M, et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev. 2008;22(10):1325-1330. (Pubitemid 351717522)
53. Shi X, Ma YQ, Tu Y, et al. The MIG-2/integrin interaction strengthens cell-matrix adhesion and modulates cell motility. J Biol Chem. 2007; 282(28):20455-20466. (Pubitemid 47100027)
54. Kloeker S, Major MB, Calderwood DA, Ginsberg MH, Jones DA, Beckerle MC. The Kindler syndrome protein is regulated by transforming growth factor-beta and involved in integrin-mediated adhesion. J Biol Chem. 2004;279(8): 6824-6833. (Pubitemid 38248824)
55. Tu Y, Wu S, Shi X, Chen K, Wu C. Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell. 2003;113(1):37-47. (Pubitemid 36411958)
56. Harburger DS, Bouaouina M, Calderwood DA. Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects. J Biol Chem. 2009;284(17):11485-11497.
57. Ma YQ, Qin J, Wu C, Plow EF. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J Cell Biol. 2008; 181(3):439-446. (Pubitemid 351645034)
58. Bledzka K, Bialkowska K, Nie H, et al. Tyrosine phosphorylation of integrin beta3 regulates kindlin-2 binding and integrin activation. J Biol Chem. 2010;285(40):30370-30374.
59. Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC 2nd. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest. 2005;115(3): 680-687. (Pubitemid 40322242)
60. Lafuente EM, van Puijenbroek AA, Krause M, et al. RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1- induced adhesion. Dev Cell. 2004;7(4):585-595. (Pubitemid 39341843)
61. Ye F, Liu J, Winkler H, Taylor KA. Integrin alpha IIb beta 3 in a membrane environment remains the same height after Mn2+ activation when observed by cryoelectron tomography. J Mol Biol. 2008;378(5):976-986.
62. Gailit J, Ruoslahti E. Regulation of the fibronectin receptor affinity by divalent cations. J Biol Chem. 1988;263(26):12927-12932.
63. Parise LV, Phillips DR. Platelet membrane glycoprotein IIb-IIIa complex incorporated into phospholipid vesicles: preparation and morphology. J Biol Chem. 1985;260(3):1750-1756. (Pubitemid 15145454)
64. Parise LV, Phillips DR. Reconstitution of the purified platelet fibrinogen receptor: fibrinogen binding properties of the glycoprotein IIb-IIIa complex. J Biol Chem. 1985;260(19):10698-10707. (Pubitemid 16252251)
65. Denisov IG, Grinkova YV, Lazarides AA, Sligar SG. Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size. J Am Chem Soc. 2004;126(11):3477-3487. (Pubitemid 38366738)
66. Goodman T, Bussmann E, Williams C, Taveras M, Britt D. Electrostatic force microscopy analysis of lipid miscibility in two-component monolayers. Langmuir. 2004;20(9):3684-3689.
67. Massari S, Colonna R. Lipid miscibility and size increase of vesicles composed of two phosphatidylcholines. Biochim Biophys Acta. 1986;863(2): 264-276. (Pubitemid 17219336)
68. Phillips DR, Baughan AK. Fibrinogen binding to human platelet plasma membranes: identification of two steps requiring divalent cations. J Biol Chem. 1983;258(17):10240-10246. (Pubitemid 14241180)
69. Brass LF, Shattil SJ. Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets. J Clin Invest. 1984;73(3):626-632. (Pubitemid 14156841)
70. Elices MJ, Urry LA, Hemler ME. Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol. 1991;112(1):169-181. (Pubitemid 21909609)
71. Yanai T, Shimo-Oka T, Ii I. Manganese ion elicits a binding activity of placenta vitronectin receptor to fibronectin cell-binding domain. Cell Struct Funct. 1991;16(2):149-156.
72. Dransfield I, Cabanas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol. 1992;116(1):219-226.
73. Kirchhofer D, Gailit J, Ruoslahti E, Grzesiak J, Pierschbacher MD. Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa. J Biol Chem. 1990;265(30):18525-18530.
74. Sonnenberg A, Modderman PW, Hogervorst F. Laminin receptor on platelets is the integrin VLA-6. Nature. 1988;336(6198):487-489.
75. Kern A, Eble J, Golbik R, Kuhn K. Interaction of type IV collagen with the isolated integrins alpha 1 beta 1 and alpha 2 beta 1. Eur J Biochem. 1993;215(1):151-159. (Pubitemid 23211136)
76. Shimizu Y, Mobley JL. Distinct divalent cation requirements for integrin-mediated CD4+ T lymphocyte adhesion to ICAM-1, fibronectin, VCAM-1, and invasin. J Immunol. 1993;151(8): 4106-4115. (Pubitemid 23298743)
77. Berlin C, Berg EL, Briskin MJ, et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 1993;74(1):185-195. (Pubitemid 23219889)
78. Ni H, Li A, Simonsen N, Wilkins JA. Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain. J Biol Chem. 1998;273(14):7981-7987. (Pubitemid 28168847)
79. Kim M, Carman CV, Springer TA. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science. 2003;301(5640): 1720-1725. (Pubitemid 37174365)
80. Chigaev A, Buranda T, Dwyer DC, Prossnitz ER, Sklar LA. FRET detection of cellular alpha4-integrin conformational activation. Biophys J. 2003; 85(6):3951-3962. (Pubitemid 37490304)
81. Kamata T, Handa M, Sato Y, Ikeda Y, Aiso S. Membrane-proximal alpha/beta stalk interactions differentially regulate integrin activation. J Biol Chem. 2005;280(26):24775-24783. (Pubitemid 40934568)
82. Smith JW, Piotrowicz RS, Mathis D. A mechanism for divalent cation regulation of beta 3-integrins. J Biol Chem. 1994;269(2):960-967. (Pubitemid 24032470)
83. Frelinger AL 3rd, Du XP, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem. 1991;266(26):17106-17111. (Pubitemid 21907912)
84. Frelinger AL 3rd, Lam SC, Plow EF, Smith MA, Loftus JC, Ginsberg MH. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem. 1988;263(25):12397-12402. (Pubitemid 19000419)
85. Byron A, Humphries JD, Askari JA, Craig SE, Mould AP, Humphries MJ. Anti-integrin monoclonal antibodies. J Cell Sci. 2009;122(22):4009-4011.
86. Li R, Mitra N, Gratkowski H, et al. Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations. Science. 2003; 300(5620):795-798. (Pubitemid 36532114)
87. Yin H, Litvinov RI, Vilaire G, et al. Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb. J Biol Chem. 2006;281(48):36732-36741. (Pubitemid 46042140)
88. Li R, Gorelik R, Nanda V, et al. Dimerization of the transmembrane domain of integrin alphaIIb subunit in cell membranes. J Biol Chem. 2004; 279(25):26666-26673. (Pubitemid 38798824)
89. Kim C, Lau TL, Ulmer TS, Ginsberg MH. Interactions of platelet integrin alphaIIb and beta3 transmembrane domains in mammalian cell membranes and their role in integrin activation. Blood. 2009;113(19):4747-4753.
90. Yin H, Slusky JS, Berger BW, et al. Computational design of peptides that target transmembrane helices. Science. 2007;315(5820):1817-1822. (Pubitemid 46580135)
91. Smith JW, Yan B, Landry F, Lombardo CR. Redox control of integrin adhesion receptors. Methods Enzymol. 2002;353:156-163. (Pubitemid 34625589)
92. Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem. 2000;275(51):39964-39972. (Pubitemid 32064618)
93. Chigaev A, Zwartz GJ, Buranda T, Edwards BS, Prossnitz ER, Sklar LA. Conformational regulation of alpha 4 beta 1-integrin affinity by reducing agents: "inside-out" signaling is independent of and additive to reduction-regulated integrin activation. J Biol Chem. 2004;279(31):32435-32443. (Pubitemid 39014698)
94. Du XP, Plow EF, Frelinger AL 3rd, O'Toole TE, Loftus JC, Ginsberg MH. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell. 1991;65(3):409-416. (Pubitemid 121002050)
95. Beer JH, Springer KT, Coller BS. Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood. 1992;79(1):117-128.
96. O'Toole TE, Mandelman D, Forsyth J, Shattil SJ, Plow EF, Ginsberg MH. Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha IIb. Science. 1991; 254(5033):845-847. (Pubitemid 21917409)
97. Zou Z, Schmaier AA, Cheng L, et al. Negative regulation of activated alpha-2 integrins during thrombopoiesis. Blood. 2009;113(25):6428-6439.
98. Lu CF, Springer TA. The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1. J Immunol. 1997;159(1): 268-278. (Pubitemid 127493709)
99. O'Toole TE, Katagiri Y, Faull RJ, et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol. 1994;124(6):1047-1059. (Pubitemid 24109406)
100. Hughes PE, Diaz-Gonzalez F, Leong L, et al. Breaking the integrin hinge: a defined structural constraint regulates integrin signaling. J Biol Chem. 1996;271(12):6571-6574.
101. Luo BH, Carman CV, Takagi J, Springer TA. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci U S A. 2005;102(10):3679-3684. (Pubitemid 40354671)
102. Li W, Metcalf DG, Gorelik R, et al. A push-pull mechanism for regulating integrin function. Proc Natl Acad Sci U S A. 2005;102(5):1424-1429. (Pubitemid 40209186)
103. Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct. 2002;31:485-516. (Pubitemid 34666842)
104. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by integrin alpha2beta1. Cell. 2000;101(1): 47-56.
105. Emsley J, King SL, Bergelson JM, Liddington RC. Crystal structure of the I domain from integrin alpha2beta1. J Biol Chem. 1997;272(45):28512-28517. (Pubitemid 27517800)
106. Lee JO, Bankston LA, Arnaout MA, Liddington RC. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure. 1995;3(12):1333-1340. (Pubitemid 3012265)
107. Luo BH, Strokovich K, Walz T, Springer TA, Takagi J. Allosteric beta1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem. 2004;279(26):27466-27471. (Pubitemid 38812586)
108. Takagi J, Strokovich K, Springer TA, Walz T. Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J. 2003;22(18):4607-4615. (Pubitemid 37162897)
109. Luo BH, Springer TA, Takagi J. Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci U S A. 2003;100(5):2403-2408. (Pubitemid 36297511)
110. Li R, Rieu P, Griffith DL, Scott D, Arnaout MA. Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol. 1998;143(6): 1523-1534. (Pubitemid 29006500)
111. Shimaoka M, Shifman JM, Jing H, Takagi J, Mayo SL, Springer TA. Computational design of an integrin I domain stabilized in the open high affinity conformation. Nat Struct Biol. 2000;7(8):674-678. (Pubitemid 30636680)
112. Aquilina A, Korda M, Bergelson JM, Humphries MJ, Farndale RW, Tuckwell D. A novel gain-of-function mutation of the integrin alpha2 VWFA domain. Eur J Biochem. 2002;269(4):1136-1144. (Pubitemid 34175372)
113. Luo BH, Karanicolas J, Harmacek LD, Baker D, Springer TA. Rationally designed integrin beta3 mutants stabilized in the high affinity conformation. J Biol Chem. 2009;284(6):3917-3924.
114. Shimaoka M, Lu C, Salas A, Xiao T, Takagi J, Springer TA. Stabilizing the integrin alpha M inserted domain in alternative conformations with a range of engineered disulfide bonds. Proc Natl Acad Sci U S A. 2002;99(26):16737-16741. (Pubitemid 36034042)
115. Shimaoka M, Lu C, Palframan RT, et al. Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci U S A. 2001;98(11): 6009-6014. (Pubitemid 32488184)
116. Lu C, Shimaoka M, Zang Q, Takagi J, Springer TA. Locking in alternate conformations of the integrin alphaLbeta2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci U S A. 2001;98(5): 2393-2398. (Pubitemid 32209493)
117. Lu C, Shimaoka M, Ferzly M, Oxvig C, Takagi J, Springer TA. An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc Natl Acad Sci U S A. 2001;98(5):2387-2392. (Pubitemid 32209492)
118. Luo BH, Takagi J, Springer TA. Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides. J Biol Chem. 2004; 279(11):10215-10221. (Pubitemid 38372626)
119. Blue R, Li J, Steinberger J, Murcia M, Filizola M, Coller BS. Effects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3. J Biol Chem. 2010;285(23):17604-17613.
120. Moser M, Legate KR, Zent R, Fassler R. The tail of integrins, talin, and kindlins. Science. 2009; 324(5929):895-899.